Neoadjuvant, adjuvant, and palliative treatment with imatinib in patients with gastrointestinal stromal tumors. Background: Soft tissue sarcomas are often treated by inadequate resection lacking ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a ...

Overall, soft tissue sarcoma has a positive 5-year survival rate. This can vary slightly according to age, sex, and treatment type. Soft tissue sarcoma is a general term used to describe cancers that ...

Soft tissue sarcomas are a group of rare cancers that can occur in almost any part of the body and develop in tissues like muscle, fat, and nerves. The most common types are leiomyosarcoma, ...

Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...

The FDA has granted orphan drug designation (ODD) to LP-284, a next-generation acylfulvene small molecule, for the treatment ...

Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective A total of 122 patients were included in the ...

As part of Elucent’s mission to lead innovation in real-time localization and surgical guidance for soft tissue excision in the treatment of cancer and other diseases, the EnVisio X1 platform sets a ...

Sixth overall for Lantern’s A.I.-driven precision oncology pipelineOrphan designation expands LP-284's potential for an ...